Rival Signals and Project Selection: Insights from the Drug Development Process
Published Online:4 Jan 2023https://doi.org/10.1287/mnsc.2022.4642
- Cited by
- 11 March 2026 | Journal of Economic Surveys, Vol. 19
- 25 April 2025 | Asia-Pacific Journal of Operational Research, Vol. 43, No. 01
- 1 January 2026 | SSRN Electronic Journal, Vol. 46
- 26 December 2025 | Journal of the Operational Research Society
- 9 February 2025 | Concurrent Engineering, Vol. 33, No. 1-4
- 20 November 2025 | Management Science, Vol. 0, No. 0
- 17 October 2025 | Management Science, Vol. 0, No. 0
- 18 October 2024 | Management Science, Vol. 71, No. 7
- Finance Research Letters, Vol. 77
- International Review of Economics & Finance, Vol. 98
- Research Policy, Vol. 54, No. 1
- 23 July 2024 | Managerial and Decision Economics, Vol. 45, No. 8
- IEEE Transactions on Engineering Management, Vol. 71
- 6 July 2023 | Manufacturing & Service Operations Management, Vol. 25, No. 6
- 1 January 2023 | SSRN Electronic Journal, Vol. 144
- 1 January 2023 | SSRN Electronic Journal, Vol. 3
- SSRN Electronic Journal, Vol. 67
Volume 69, Issue 9
September 2023
Pages 4973-5693, iii-iv
Article Information
Supplemental Material
Metrics
Information
- Received:July 06, 2020
- Accepted:October 22, 2022
- Published Online:January 04, 2023
Copyright © 2023, INFORMS
Cite as
Panos Markou, Stylianos Kavadias, Nektarios Oraiopoulos (2023) Rival Signals and Project Selection: Insights from the Drug Development Process. Management Science 69(9):5298-5315.
https://doi.org/10.1287/mnsc.2022.4642
Keywords
The authors thank Dr. David Brown and Dr. Hitesh Sanganee for their insights in the pharmaceutical drug discovery and development context, as well as attendees at the European TOM Day at INSEAD and the 2018 M&SOM Annual Meeting. The authors also thank three anonymous reviewers, the associate editor, and the department editor for their constructive comments and suggestions.
